Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Guido Tricot

Concepts (548)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
147
2024
2954
9.380
Why?
Hematopoietic Stem Cell Transplantation
28
2024
567
3.750
Why?
Pyrazines
20
2023
187
2.760
Why?
Antineoplastic Combined Chemotherapy Protocols
35
2024
990
2.610
Why?
Boronic Acids
19
2014
182
2.550
Why?
Thalidomide
28
2023
377
2.510
Why?
Transplantation, Autologous
30
2024
469
2.030
Why?
Antineoplastic Agents
30
2020
1186
2.010
Why?
Transplantation Conditioning
9
2019
84
1.530
Why?
Drug Resistance, Neoplasm
17
2020
314
1.520
Why?
Paraproteinemias
8
2018
72
1.330
Why?
Humans
157
2024
50208
1.230
Why?
Neoplastic Stem Cells
5
2020
103
1.220
Why?
Protease Inhibitors
6
2011
58
1.110
Why?
Venous Thrombosis
7
2009
90
1.080
Why?
Melphalan
16
2023
174
1.040
Why?
Stem Cell Transplantation
13
2023
182
1.030
Why?
Angiogenesis Inhibitors
9
2009
188
1.020
Why?
Aged
58
2024
9405
1.000
Why?
Gene Expression Regulation, Neoplastic
13
2020
828
0.970
Why?
Hematopoietic Stem Cell Mobilization
5
2014
57
0.970
Why?
Prognosis
33
2024
1954
0.960
Why?
Middle Aged
60
2024
12206
0.930
Why?
Alkaline Phosphatase
5
2011
95
0.880
Why?
Busulfan
3
2019
19
0.880
Why?
Treatment Outcome
39
2022
5155
0.820
Why?
Plasma Cells
11
2023
223
0.810
Why?
Dexamethasone
16
2024
430
0.780
Why?
Male
68
2024
25399
0.730
Why?
Chromosome Aberrations
9
2008
297
0.680
Why?
Female
64
2024
26635
0.680
Why?
Thromboembolism
3
2009
54
0.680
Why?
Neoplasm Proteins
6
2021
324
0.650
Why?
Chromosomes, Human, Pair 13
6
2008
38
0.630
Why?
Disease-Free Survival
14
2019
454
0.590
Why?
Immunoglobulin Light Chains
3
2016
82
0.590
Why?
Survival Rate
18
2019
901
0.590
Why?
Bone Remodeling
2
2010
149
0.580
Why?
Anticoagulants
5
2009
253
0.580
Why?
Gene Expression Profiling
18
2023
1037
0.580
Why?
Blood Transfusion
1
2018
126
0.570
Why?
Immunologic Factors
5
2012
114
0.570
Why?
Cell Line, Tumor
18
2023
1416
0.540
Why?
Follow-Up Studies
21
2024
2190
0.540
Why?
Receptors, Retinoic Acid
2
2013
23
0.530
Why?
Antineoplastic Agents, Alkylating
7
2008
74
0.520
Why?
Proteasome Inhibitors
6
2018
104
0.520
Why?
IMP Dehydrogenase
2
2006
3
0.520
Why?
Mycophenolic Acid
2
2006
18
0.510
Why?
Adult
38
2024
13324
0.510
Why?
Clinical Trials as Topic
9
2022
466
0.510
Why?
Combined Modality Therapy
13
2008
636
0.490
Why?
Recurrence
16
2018
662
0.490
Why?
Cell Proliferation
15
2020
1013
0.490
Why?
Antigens, Neoplasm
5
2007
152
0.470
Why?
Up-Regulation
5
2020
453
0.470
Why?
Antibodies, Monoclonal
3
2015
460
0.470
Why?
Apoptosis
9
2019
1112
0.470
Why?
Retrospective Studies
18
2024
6134
0.460
Why?
Osteogenesis
3
2012
353
0.460
Why?
Venous Thromboembolism
3
2011
68
0.450
Why?
Animals
30
2024
13246
0.450
Why?
Survival Analysis
12
2021
666
0.450
Why?
Disease Progression
12
2019
831
0.440
Why?
Signal Transduction
12
2020
1622
0.440
Why?
Doxorubicin
8
2018
239
0.440
Why?
Bone Diseases
3
2012
99
0.430
Why?
Neoplasms, Second Primary
2
2024
78
0.420
Why?
Thrombosis
4
2012
248
0.420
Why?
Central Nervous System Neoplasms
2
2004
64
0.410
Why?
T-Lymphocytes
10
2024
339
0.410
Why?
Myeloablative Agonists
5
2014
30
0.400
Why?
Bone Marrow
7
2022
363
0.400
Why?
Transplantation, Homologous
6
2004
138
0.390
Why?
Oligopeptides
2
2013
91
0.390
Why?
Osteoblasts
4
2007
450
0.390
Why?
Risk Factors
18
2018
3629
0.390
Why?
Hematopoietic Stem Cells
2
2010
184
0.380
Why?
Meta-Analysis as Topic
2
2015
38
0.370
Why?
Salvage Therapy
9
2012
139
0.370
Why?
Granulocyte Colony-Stimulating Factor
2
2008
61
0.370
Why?
Tumor Microenvironment
3
2024
233
0.360
Why?
Bone Marrow Transplantation
5
2007
116
0.360
Why?
Mice
19
2024
5759
0.360
Why?
Enzyme Inhibitors
2
2019
386
0.350
Why?
Membrane Proteins
4
2017
353
0.350
Why?
Ultrasonography, Doppler
2
2007
42
0.350
Why?
Monoclonal Gammopathy of Undetermined Significance
4
2024
115
0.350
Why?
Remission Induction
10
2008
207
0.340
Why?
Prospective Studies
9
2019
2379
0.340
Why?
Cell Cycle Proteins
2
2021
166
0.340
Why?
Neoplasm, Residual
4
2022
165
0.340
Why?
Myelodysplastic Syndromes
4
2007
81
0.330
Why?
B-Lymphocytes
4
2021
170
0.330
Why?
Waldenstrom Macroglobulinemia
3
2018
40
0.320
Why?
Immunosuppressive Agents
3
2005
222
0.320
Why?
Lymphoma, B-Cell
3
2021
63
0.320
Why?
Bone Neoplasms
1
2010
183
0.310
Why?
Neovascularization, Pathologic
1
2009
162
0.310
Why?
Killer Cells, Natural
4
2024
107
0.300
Why?
Brain Diseases, Metabolic
1
2007
5
0.290
Why?
Proteasome Endopeptidase Complex
4
2018
117
0.290
Why?
Aged, 80 and over
11
2019
3154
0.290
Why?
Hyperammonemia
1
2007
18
0.290
Why?
Chromosome Deletion
3
2008
140
0.290
Why?
Dose-Response Relationship, Drug
6
2016
1378
0.290
Why?
Amyloidosis
2
2007
81
0.290
Why?
Farnesyltranstransferase
1
2006
5
0.290
Why?
Research Design
1
2009
342
0.290
Why?
Thrombophilia
4
2009
18
0.280
Why?
Peripheral Blood Stem Cell Transplantation
4
2014
53
0.280
Why?
Small Molecule Libraries
2
2019
68
0.280
Why?
Hemostasis
1
2007
55
0.280
Why?
Bone and Bones
1
2010
475
0.280
Why?
Sirolimus
1
2006
62
0.270
Why?
Immunotherapy, Adoptive
4
2024
157
0.270
Why?
Gastrointestinal Neoplasms
1
2006
44
0.270
Why?
Cell Survival
8
2018
602
0.270
Why?
Caspases
1
2006
104
0.260
Why?
In Situ Hybridization, Fluorescence
6
2016
259
0.260
Why?
Flow Cytometry
6
2018
476
0.250
Why?
Diploidy
2
2004
26
0.250
Why?
beta 2-Microglobulin
5
2008
38
0.250
Why?
Antibody Formation
1
2005
52
0.250
Why?
Religion
1
2005
63
0.250
Why?
Activated Protein C Resistance
4
2011
10
0.240
Why?
Case-Control Studies
10
2018
1126
0.240
Why?
Aneuploidy
1
2004
16
0.240
Why?
Enoxaparin
1
2004
27
0.240
Why?
Ubiquitination
2
2021
43
0.230
Why?
Attitude to Health
1
2005
191
0.230
Why?
Adaptation, Psychological
1
2005
223
0.230
Why?
Osteolysis
2
2022
75
0.230
Why?
Multivariate Analysis
5
2008
581
0.220
Why?
Cancer Vaccines
3
2010
78
0.220
Why?
Randomized Controlled Trials as Topic
4
2012
550
0.220
Why?
Cisplatin
6
2009
278
0.220
Why?
Cell Communication
2
2006
69
0.220
Why?
Pyrimidines
3
2015
193
0.220
Why?
Blood Coagulation
1
2003
56
0.220
Why?
Critical Illness
1
2005
288
0.210
Why?
Mice, Inbred NOD
6
2020
96
0.210
Why?
Antigens, CD34
1
2003
66
0.210
Why?
Cytogenetic Analysis
6
2007
82
0.210
Why?
Graft vs Host Disease
5
2010
75
0.210
Why?
Parathyroid Hormone
3
2010
147
0.210
Why?
Kidney
1
2007
672
0.210
Why?
Leukemia, Myeloid
1
2002
43
0.200
Why?
Cyclophosphamide
4
2003
166
0.200
Why?
STAT3 Transcription Factor
4
2015
81
0.200
Why?
Bone Resorption
2
2022
302
0.200
Why?
Chromosome Disorders
1
2002
35
0.200
Why?
Etoposide
5
2009
72
0.200
Why?
Time Factors
9
2016
2922
0.200
Why?
Hypothyroidism
1
2002
54
0.190
Why?
Cyclin-Dependent Kinase Inhibitor p21
2
2015
67
0.190
Why?
Logistic Models
5
2018
889
0.190
Why?
Chromosomes, Human, Pair 1
3
2006
93
0.190
Why?
Antibodies, Bispecific
1
2022
69
0.190
Why?
Neoplasm Recurrence, Local
4
2024
613
0.180
Why?
Cytotoxicity, Immunologic
3
2012
55
0.180
Why?
Xenograft Model Antitumor Assays
5
2019
212
0.170
Why?
Neoplasms
2
2009
1249
0.170
Why?
DNA-Binding Proteins
2
2020
428
0.170
Why?
Glucuronidase
2
2018
46
0.170
Why?
Predictive Value of Tests
5
2009
905
0.170
Why?
Proto-Oncogene Proteins c-bcl-2
2
2013
129
0.170
Why?
Hematologic Neoplasms
2
2016
99
0.170
Why?
Syndecan-1
3
2017
72
0.160
Why?
Healthcare Disparities
1
2022
268
0.160
Why?
Cytokines
4
2007
613
0.160
Why?
Osteoclasts
4
2022
428
0.160
Why?
Kaplan-Meier Estimate
6
2015
465
0.160
Why?
Hydrocarbons, Aromatic
1
2018
2
0.160
Why?
Solvents
1
2018
29
0.160
Why?
Drug Tolerance
1
2018
60
0.160
Why?
Pyridines
1
2019
131
0.160
Why?
T-Lymphocytes, Cytotoxic
3
2010
65
0.160
Why?
Jehovah's Witnesses
1
2018
6
0.160
Why?
Dendritic Cells
3
2010
133
0.160
Why?
Vincristine
3
2003
88
0.160
Why?
Cell Differentiation
4
2022
650
0.150
Why?
Platelet Count
3
2008
72
0.150
Why?
CDC2-CDC28 Kinases
2
2015
12
0.150
Why?
Risk Assessment
5
2023
1262
0.150
Why?
Iron
2
2017
122
0.150
Why?
Occupational Diseases
1
2018
88
0.150
Why?
Arsenicals
2
2010
14
0.140
Why?
Pyruvate Kinase
1
2017
7
0.140
Why?
Ascorbic Acid
1
2017
22
0.140
Why?
Oxides
2
2010
18
0.140
Why?
Drug Combinations
1
2017
126
0.140
Why?
Interleukin-6
2
2018
265
0.140
Why?
Mice, SCID
5
2018
176
0.140
Why?
Occupational Exposure
1
2018
121
0.140
Why?
Anthropometry
1
2017
92
0.140
Why?
RNA Splicing
1
2017
37
0.140
Why?
Glycolysis
1
2017
70
0.140
Why?
Factor V
3
2011
11
0.140
Why?
Immunoglobulin lambda-Chains
1
2016
15
0.140
Why?
Transcription Factors
1
2020
564
0.140
Why?
Immunotherapy
4
2006
240
0.140
Why?
Immunoglobulin kappa-Chains
1
2016
22
0.140
Why?
Incidence
3
2009
1006
0.130
Why?
Fibrinolytic Agents
2
2007
125
0.130
Why?
MicroRNAs
1
2020
355
0.130
Why?
Tumor Cells, Cultured
6
2019
468
0.130
Why?
Leukocytes, Mononuclear
2
2014
115
0.130
Why?
Reproductive History
1
2015
4
0.130
Why?
Oncolytic Virotherapy
1
2015
17
0.130
Why?
Hormone Replacement Therapy
1
2015
27
0.130
Why?
Cyclopentanes
1
2015
10
0.130
Why?
Cell Adhesion Molecules
1
2015
89
0.130
Why?
Hemorrhage
2
2007
197
0.130
Why?
Ubiquitins
1
2015
39
0.130
Why?
Cation Transport Proteins
1
2015
27
0.120
Why?
Receptors, Cell Surface
1
2015
125
0.120
Why?
Aldehyde Dehydrogenase
1
2014
26
0.120
Why?
NF-kappa B
3
2018
315
0.120
Why?
Postmenopause
1
2015
95
0.120
Why?
Drug Monitoring
1
2015
78
0.120
Why?
Intestines
1
2016
168
0.120
Why?
Leukapheresis
1
2014
14
0.120
Why?
Protein-Tyrosine Kinases
1
2015
95
0.120
Why?
Transplantation Chimera
3
2003
15
0.120
Why?
Translocation, Genetic
3
2005
264
0.120
Why?
Myeloma Proteins
2
2020
24
0.120
Why?
Antibodies
2
2024
154
0.120
Why?
Gene Deletion
3
2004
270
0.110
Why?
Body Mass Index
1
2017
656
0.110
Why?
Receptor, Parathyroid Hormone, Type 1
1
2013
24
0.110
Why?
Polymorphism, Single Nucleotide
1
2016
485
0.110
Why?
Veratrum Alkaloids
1
2013
5
0.110
Why?
Multidrug Resistance-Associated Proteins
1
2013
16
0.110
Why?
Isoxazoles
1
2013
14
0.110
Why?
Biopsy
2
2006
590
0.110
Why?
Hedgehog Proteins
1
2013
33
0.110
Why?
Sulfones
1
2013
24
0.110
Why?
Cystatin M
2
2024
20
0.110
Why?
Itraconazole
1
2013
40
0.110
Why?
Metaphase
3
2008
44
0.110
Why?
Genetic Predisposition to Disease
1
2016
509
0.110
Why?
Carrier Proteins
2
2017
306
0.110
Why?
Intercellular Adhesion Molecule-1
1
2013
63
0.110
Why?
B-Cell Maturation Antigen
2
2024
91
0.110
Why?
Wnt Proteins
1
2013
100
0.110
Why?
Renal Insufficiency
3
2009
109
0.110
Why?
Infusions, Intravenous
2
2003
213
0.100
Why?
Risk
2
2011
324
0.100
Why?
Viremia
1
2012
22
0.100
Why?
Drug Delivery Systems
2
2005
146
0.100
Why?
Chromosomes, Human, Pair 11
2
2002
54
0.100
Why?
Cytomegalovirus Infections
1
2012
35
0.100
Why?
Clinical Trials, Phase II as Topic
1
2012
44
0.100
Why?
Clinical Trials, Phase III as Topic
1
2012
43
0.100
Why?
Radiopharmaceuticals
2
2021
208
0.100
Why?
Receptors, KIR
2
2008
13
0.100
Why?
Phosphorylation
2
2020
534
0.100
Why?
Fluorodeoxyglucose F18
2
2021
194
0.100
Why?
Medical Oncology
1
2012
95
0.100
Why?
Inflammation
1
2016
604
0.100
Why?
Alcohol Drinking
1
2013
226
0.100
Why?
Ligands
2
2009
205
0.100
Why?
Reoperation
2
2004
454
0.100
Why?
Drug Evaluation, Preclinical
1
2012
143
0.100
Why?
Age Factors
3
2005
1092
0.100
Why?
Receptors, TNF-Related Apoptosis-Inducing Ligand
1
2010
6
0.090
Why?
Tretinoin
2
2009
53
0.090
Why?
TNF-Related Apoptosis-Inducing Ligand
1
2010
20
0.090
Why?
Smoking
1
2014
512
0.090
Why?
Recombinant Proteins
2
2010
487
0.090
Why?
Antineoplastic Agents, Hormonal
2
2007
48
0.090
Why?
Janus Kinase 1
1
2010
17
0.090
Why?
Macrophages
1
2013
363
0.090
Why?
MAP Kinase Kinase 1
1
2010
23
0.090
Why?
Cyclin-Dependent Kinases
1
2010
28
0.090
Why?
Down-Regulation
2
2010
349
0.090
Why?
Authorship
1
2010
12
0.090
Why?
Neoplasm Staging
3
2015
738
0.090
Why?
Extracellular Signal-Regulated MAP Kinases
1
2010
83
0.090
Why?
Conflict of Interest
1
2010
25
0.090
Why?
Drug Industry
1
2010
38
0.090
Why?
Bone Density Conservation Agents
1
2010
74
0.090
Why?
Disclosure
1
2010
39
0.090
Why?
Diphosphonates
1
2010
90
0.090
Why?
Mice, Transgenic
3
2021
550
0.080
Why?
Chromosome Banding
2
2006
24
0.080
Why?
Leukocyte Count
2
2014
72
0.080
Why?
Plasmacytoma
2
2011
42
0.080
Why?
Maximum Tolerated Dose
2
2009
37
0.080
Why?
Periodicals as Topic
1
2010
58
0.080
Why?
Cell Cycle
2
2010
232
0.080
Why?
Oligonucleotide Array Sequence Analysis
5
2014
411
0.080
Why?
Magnetic Resonance Imaging
3
2007
1541
0.080
Why?
Cryoglobulinemia
1
2008
13
0.080
Why?
Blotting, Western
3
2015
601
0.080
Why?
Cytogenetics
1
2008
23
0.080
Why?
Prednisone
2
2009
101
0.080
Why?
Vascular Endothelial Growth Factor A
1
2009
202
0.080
Why?
Pulmonary Embolism
1
2009
97
0.080
Why?
Sulfonamides
1
2009
128
0.080
Why?
Neutrophils
2
2014
148
0.080
Why?
Hemoglobins
1
2008
107
0.080
Why?
Polyethylene Glycols
1
2008
93
0.080
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2015
595
0.080
Why?
Immunophenotyping
2
2007
109
0.080
Why?
Adoptive Transfer
1
2007
40
0.080
Why?
Heparin, Low-Molecular-Weight
1
2007
20
0.080
Why?
Histocompatibility Antigens Class I
1
2007
44
0.070
Why?
CD8-Positive T-Lymphocytes
2
2024
128
0.070
Why?
Phlebography
1
2007
60
0.070
Why?
Fibrinolysis
1
2007
5
0.070
Why?
Ammonia
1
2007
72
0.070
Why?
Blood Coagulation Factors
1
2007
17
0.070
Why?
Serum Albumin
2
2008
58
0.070
Why?
Chi-Square Distribution
1
2007
278
0.070
Why?
Biomedical Research
1
2010
236
0.070
Why?
Cell Membrane
1
2007
251
0.070
Why?
Brain
2
2007
1328
0.070
Why?
Osteoprotegerin
1
2006
52
0.070
Why?
Drug Administration Schedule
2
2006
377
0.070
Why?
Models, Genetic
1
2006
170
0.070
Why?
Guanosine
1
2006
6
0.070
Why?
Antibiotics, Antineoplastic
1
2006
81
0.070
Why?
Sex Factors
3
2016
697
0.070
Why?
Femur Head Necrosis
1
2005
18
0.060
Why?
Renal Dialysis
1
2007
170
0.060
Why?
Neovascularization, Physiologic
1
2005
68
0.060
Why?
Survivors
1
2006
125
0.060
Why?
Guanosine Triphosphate
1
2004
20
0.060
Why?
Karyotyping
1
2005
83
0.060
Why?
Gene Duplication
1
2005
15
0.060
Why?
Oncogene Proteins, Fusion
1
2005
58
0.060
Why?
Tissue Donors
2
2003
113
0.060
Why?
Kidney Transplantation
1
2007
175
0.060
Why?
Proteolysis
2
2015
95
0.060
Why?
Thrombophlebitis
1
2004
24
0.060
Why?
Genomic Instability
1
2005
93
0.060
Why?
Tomography, Emission-Computed
1
2004
53
0.060
Why?
Ferritins
1
2024
30
0.060
Why?
RNA Interference
2
2015
179
0.060
Why?
Myeloid Progenitor Cells
1
2023
18
0.060
Why?
X-Ray Microtomography
1
2024
77
0.060
Why?
Chromatography, High Pressure Liquid
1
2004
327
0.060
Why?
Patient Selection
1
2005
253
0.060
Why?
Discitis
1
2003
9
0.050
Why?
Stem Cell Factor
1
2003
7
0.050
Why?
Anxiety
1
2005
275
0.050
Why?
Confidence Intervals
1
2003
156
0.050
Why?
Lymphocyte Transfusion
1
2003
10
0.050
Why?
Probability
1
2003
164
0.050
Why?
Neoplastic Cells, Circulating
1
2004
74
0.050
Why?
Interferons
1
2002
38
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Cell Count
1
2003
149
0.050
Why?
Cyclosporine
1
2003
65
0.050
Why?
Drug Therapy, Combination
2
2017
381
0.050
Why?
Geography
1
2022
60
0.050
Why?
Tacrolimus
1
2003
52
0.050
Why?
Thyroid Function Tests
1
2002
24
0.050
Why?
Blood Group Incompatibility
1
2002
5
0.050
Why?
Stromal Cells
1
2002
72
0.050
Why?
Administration, Oral
1
2003
434
0.050
Why?
ABO Blood-Group System
1
2002
15
0.050
Why?
Leukemia, Promyelocytic, Acute
1
2002
11
0.050
Why?
Thyrotropin
1
2002
48
0.050
Why?
Drug Interactions
1
2002
208
0.050
Why?
Fatal Outcome
1
2002
195
0.050
Why?
Cell Division
1
2002
295
0.050
Why?
Chromosome Mapping
3
2006
156
0.050
Why?
Graft Survival
1
2002
150
0.050
Why?
Genomics
1
2023
285
0.050
Why?
RANK Ligand
1
2022
179
0.050
Why?
Acute Disease
1
2002
368
0.050
Why?
Cells, Cultured
1
2005
1581
0.050
Why?
Young Adult
3
2015
3981
0.050
Why?
Cluster Analysis
3
2006
235
0.050
Why?
Tomography, X-Ray Computed
1
2006
1161
0.050
Why?
Depression
1
2005
570
0.040
Why?
Neoplasm Transplantation
1
2020
85
0.040
Why?
Odds Ratio
2
2016
546
0.040
Why?
Pain
1
2003
381
0.040
Why?
Postoperative Complications
1
2007
996
0.040
Why?
3' Untranslated Regions
1
2020
52
0.040
Why?
Staphylococcal Infections
1
2003
269
0.040
Why?
Positron-Emission Tomography
1
2021
294
0.040
Why?
Crystallography, X-Ray
1
2019
148
0.040
Why?
Antigens, CD
2
2015
221
0.040
Why?
Protein Conformation
1
2019
168
0.040
Why?
Mice, Nude
1
2019
254
0.040
Why?
Bone Marrow Cells
2
2015
190
0.040
Why?
Coculture Techniques
2
2012
146
0.040
Why?
Mice, Inbred BALB C
1
2019
305
0.040
Why?
Receptors, Interleukin-6
1
2018
22
0.040
Why?
Antigens, CD19
1
2018
24
0.040
Why?
Microarray Analysis
1
2018
73
0.040
Why?
Drug Resistance
1
2018
64
0.040
Why?
Disease Management
1
2020
176
0.040
Why?
Interferon-gamma
2
2010
176
0.040
Why?
Protein Stability
1
2018
44
0.040
Why?
Gene Knockdown Techniques
1
2018
106
0.040
Why?
Epidemiologic Methods
2
2008
49
0.040
Why?
Aerobiosis
1
2017
14
0.040
Why?
Cross-Sectional Studies
1
2022
1554
0.040
Why?
Microfilament Proteins
1
2017
43
0.040
Why?
Thyroid Hormones
1
2017
18
0.040
Why?
HLA-A Antigens
2
2007
10
0.040
Why?
Calcium-Binding Proteins
1
2017
54
0.040
Why?
Transplantation, Heterologous
1
2017
75
0.040
Why?
Vaccination
2
2010
271
0.040
Why?
Polycomb Repressive Complex 1
1
2016
3
0.040
Why?
Transmembrane Activator and CAML Interactor Protein
1
2016
6
0.040
Why?
Proto-Oncogene Proteins c-myc
1
2017
50
0.030
Why?
Genetic Loci
1
2016
49
0.030
Why?
Protein Binding
1
2018
665
0.030
Why?
Antibodies, Neoplasm
2
2006
28
0.030
Why?
Mice, Inbred ICR
1
2016
22
0.030
Why?
Mice, Knockout
1
2018
846
0.030
Why?
Microscopy, Electron, Transmission
1
2015
75
0.030
Why?
Reoviridae
1
2015
25
0.030
Why?
Genome-Wide Association Study
1
2016
166
0.030
Why?
Tumor Burden
1
2016
131
0.030
Why?
ras Proteins
1
2015
64
0.030
Why?
Receptors, Transferrin
1
2015
16
0.030
Why?
Repressor Proteins
1
2016
153
0.030
Why?
Side-Population Cells
1
2015
3
0.030
Why?
RNA, Messenger
2
2010
1108
0.030
Why?
Lentivirus
1
2015
16
0.030
Why?
Retinal Dehydrogenase
1
2014
10
0.030
Why?
Family
1
2016
174
0.030
Why?
Disease Models, Animal
2
2013
1458
0.030
Why?
Adenine
1
2015
32
0.030
Why?
Molecular Targeted Therapy
1
2016
121
0.030
Why?
Models, Biological
1
2018
723
0.030
Why?
Cyclin B
1
2014
4
0.030
Why?
Reactive Oxygen Species
1
2017
408
0.030
Why?
G2 Phase Cell Cycle Checkpoints
1
2014
8
0.030
Why?
CDC2 Protein Kinase
1
2014
16
0.030
Why?
Portraits as Topic
1
2014
2
0.030
Why?
Cell Lineage
1
2014
84
0.030
Why?
Drug Synergism
1
2014
151
0.030
Why?
Mitosis
1
2014
93
0.030
Why?
beta Catenin
1
2015
102
0.030
Why?
Piperidines
1
2015
98
0.030
Why?
Drug Screening Assays, Antitumor
1
2014
140
0.030
Why?
Pyrazoles
1
2015
114
0.030
Why?
Cell Movement
1
2015
249
0.030
Why?
Proportional Hazards Models
2
2006
410
0.030
Why?
Patient Safety
1
2014
102
0.030
Why?
Peptide Library
1
2013
16
0.030
Why?
Receptors, IgG
1
2013
22
0.030
Why?
Adolescent
2
2014
6390
0.030
Why?
Chromosomal Instability
1
2013
16
0.030
Why?
Epitopes
1
2013
61
0.030
Why?
Membrane Glycoproteins
2
2006
246
0.030
Why?
Protein Kinase Inhibitors
1
2014
206
0.030
Why?
Antibodies, Monoclonal, Murine-Derived
1
2012
47
0.030
Why?
Immunoglobulin M
1
2012
52
0.030
Why?
Interleukin Receptor Common gamma Subunit
1
2012
8
0.030
Why?
NK Cell Lectin-Like Receptor Subfamily K
1
2012
9
0.030
Why?
Cytomegalovirus
1
2012
27
0.030
Why?
Viral Load
1
2012
77
0.030
Why?
Virus Activation
1
2012
32
0.030
Why?
Peripheral Nervous System Diseases
1
2012
57
0.030
Why?
Interleukin-2
1
2012
72
0.030
Why?
Immunoenzyme Techniques
1
2012
145
0.020
Why?
Arkansas
2
2008
1985
0.020
Why?
Viper Venoms
1
2011
7
0.020
Why?
Asymptomatic Diseases
1
2011
36
0.020
Why?
Neoadjuvant Therapy
1
2012
117
0.020
Why?
Protein C
1
2011
18
0.020
Why?
Lymphocyte Activation
1
2012
172
0.020
Why?
Chemotherapy, Adjuvant
1
2011
120
0.020
Why?
Interferon Regulatory Factor-1
1
2010
14
0.020
Why?
Cell Growth Processes
1
2010
22
0.020
Why?
Antiviral Agents
1
2012
173
0.020
Why?
Immunoglobulin Idiotypes
1
2010
5
0.020
Why?
CD40 Ligand
1
2010
14
0.020
Why?
Hypersensitivity, Delayed
1
2010
21
0.020
Why?
Interleukin-4
1
2010
43
0.020
Why?
Adjuvants, Immunologic
1
2010
51
0.020
Why?
Immunity, Cellular
1
2010
70
0.020
Why?
Diagnosis, Differential
2
2004
1043
0.020
Why?
Mutation
1
2015
1294
0.020
Why?
Physician's Role
1
2010
47
0.020
Why?
RNA, Small Interfering
1
2010
215
0.020
Why?
Practice Guidelines as Topic
1
2012
449
0.020
Why?
Education, Medical, Continuing
1
2010
68
0.020
Why?
Hyperhomocysteinemia
1
2009
29
0.020
Why?
Protein Isoforms
1
2009
119
0.020
Why?
Indazoles
1
2009
46
0.020
Why?
Cytotoxicity Tests, Immunologic
1
2008
28
0.020
Why?
Algorithms
1
2012
618
0.020
Why?
Safety
1
2009
77
0.020
Why?
Vasculitis
1
2008
29
0.020
Why?
Ploidies
1
2008
11
0.020
Why?
Haplotypes
1
2008
84
0.020
Why?
Double-Blind Method
1
2009
688
0.020
Why?
Twins
1
2007
33
0.020
Why?
Age Distribution
1
2007
168
0.020
Why?
C-Reactive Protein
1
2008
143
0.020
Why?
Creatinine
1
2007
141
0.020
Why?
Multigene Family
1
2006
56
0.020
Why?
Blood Proteins
1
2007
82
0.020
Why?
Partial Thromboplastin Time
1
2006
12
0.020
Why?
Cyclin D
1
2006
18
0.020
Why?
Syndecans
1
2006
34
0.020
Why?
Heterozygote
1
2006
81
0.020
Why?
Cyclins
1
2006
38
0.020
Why?
RNA, Neoplasm
1
2006
45
0.020
Why?
Proteoglycans
1
2006
80
0.020
Why?
Amiloride
1
2005
8
0.020
Why?
HLA-A2 Antigen
1
2005
11
0.020
Why?
Transduction, Genetic
1
2005
45
0.020
Why?
Leukemia, Myeloid, Acute
1
2007
185
0.020
Why?
Cell Line
1
2008
1021
0.020
Why?
Radiography
1
2007
491
0.020
Why?
Data Interpretation, Statistical
1
2006
157
0.020
Why?
Neoplasms, Experimental
1
2006
114
0.020
Why?
Interferon-alpha
1
2005
48
0.020
Why?
Sensitivity and Specificity
1
2007
863
0.020
Why?
Monocytes
1
2005
131
0.020
Why?
Databases, Factual
1
2007
657
0.010
Why?
Clone Cells
1
2004
78
0.010
Why?
Antibodies, Monoclonal, Humanized
1
2005
225
0.010
Why?
Monosomy
1
2003
5
0.010
Why?
Trisomy
1
2003
31
0.010
Why?
Fibroblasts
1
2005
351
0.010
Why?
History, 21st Century
1
2003
55
0.010
Why?
History, 20th Century
1
2003
99
0.010
Why?
Interphase
1
2003
13
0.010
Why?
Plasmapheresis
1
2003
11
0.010
Why?
Back Pain
1
2003
39
0.010
Why?
United States
1
2013
4874
0.010
Why?
Pore Forming Cytotoxic Proteins
1
2002
9
0.010
Why?
Perforin
1
2002
11
0.010
Why?
Anemia
1
2003
67
0.010
Why?
Cohort Studies
1
2006
1422
0.010
Why?
Antigen Presentation
1
2002
25
0.010
Why?
Red-Cell Aplasia, Pure
1
2002
7
0.010
Why?
Prevalence
1
2005
951
0.010
Why?
Quality Assurance, Health Care
1
2003
149
0.010
Why?
Erythrocyte Transfusion
1
2002
46
0.010
Why?
Cell Culture Techniques
1
2002
99
0.010
Why?
DNA, Neoplasm
1
2002
147
0.010
Why?
Graft Rejection
1
2002
168
0.010
Why?
Kidney Diseases
1
2003
214
0.010
Why?
Anti-Bacterial Agents
1
2003
747
0.010
Why?
Tricot's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description